184 related articles for article (PubMed ID: 3053212)
1. EEDQ, a tool for ex vivo measurement of occupancy of D-1 and D-2 dopamine receptors.
Nowak G; Arnt J; Hyttel J
Eur J Pharmacol; 1988 Aug; 153(2-3):309-11. PubMed ID: 3053212
[TBL] [Abstract][Full Text] [Related]
2. An autoradiographic study of the differential effects of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) on striatal and extrastriatal D-1 and D-2 dopamine receptors in the rat.
Gnanalingham KK; Hunter AJ; Jenner P; Marsden CD
Neuropharmacology; 1994 May; 33(5):647-55. PubMed ID: 7936100
[TBL] [Abstract][Full Text] [Related]
3. Selective unilateral inactivation of striatal D1 and D2 dopamine receptor subtypes by EEDQ: turning behavior elicited by D2 dopamine receptor agonists.
Giorgi O; Biggio G
Brain Res; 1990 Nov; 533(1):53-9. PubMed ID: 1982234
[TBL] [Abstract][Full Text] [Related]
4. Dopamine receptor occupancy in vivo: measurement using N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ).
Saller CF; Kreamer LD; Adamovage LA; Salama AI
Life Sci; 1989; 45(10):917-29. PubMed ID: 2529407
[TBL] [Abstract][Full Text] [Related]
5. Selective blockade of dopamine D-1 receptor by SCH 23390 affects dopamine agonist binding to 3H-spiperone labeled D-2 receptors in rat striatum.
Zhang X; Segawa T
Jpn J Pharmacol; 1989 Jul; 50(3):333-45. PubMed ID: 2569545
[TBL] [Abstract][Full Text] [Related]
6. Dissociation of the striatal D-2 dopamine receptor from adenylyl cyclase following 6-hydroxydopamine-induced denervation.
Thomas KL; Rose S; Jenner P; Marsden CD
Biochem Pharmacol; 1992 Jul; 44(1):73-82. PubMed ID: 1321630
[TBL] [Abstract][Full Text] [Related]
7. Dopamine D-1 receptor agonists combined with the selective D-2 agonist quinpirole facilitate the expression of oral stereotyped behaviour in rats.
Arnt J; Hyttel J; Perregaard J
Eur J Pharmacol; 1987 Jan; 133(2):137-45. PubMed ID: 2949991
[TBL] [Abstract][Full Text] [Related]
8. In vivo assessment of release and metabolism of dopamine in the ventrolateral striatum of awake rats following administration of dopamine D1 and D2 receptor agonists and antagonists.
See RE; Sorg BA; Chapman MA; Kalivas PW
Neuropharmacology; 1991 Dec; 30(12A):1269-74. PubMed ID: 1686300
[TBL] [Abstract][Full Text] [Related]
9. Selective and stereospecific interactions of R-SK & F 38393 with [3H]piflutixol but not [3H]spiperone binding to striatal D1 and D2 dopamine receptors: comparisons with SCH 23390.
O'Boyle KM; Waddington JL
Eur J Pharmacol; 1984 Mar; 98(3-4):433-6. PubMed ID: 6144559
[TBL] [Abstract][Full Text] [Related]
10. Differential involvement of dopamine D-1 and D-2 receptors in the circling behaviour induced by apomorphine, SK & F 38393, pergolide and LY 171555 in 6-hydroxydopamine-lesioned rats.
Arnt J; Hyttel J
Psychopharmacology (Berl); 1985; 85(3):346-52. PubMed ID: 2860689
[TBL] [Abstract][Full Text] [Related]
11. Structural determinants of selective affinity for brain D-1 dopamine receptors within a series of 1-phenyl-1H-3-benzazepine analogues of SK&F 38393 and SCH 23390.
O'Boyle KM; Waddington JL
Eur J Pharmacol; 1985 Sep; 115(2-3):291-5. PubMed ID: 2866103
[TBL] [Abstract][Full Text] [Related]
12. SCH 23390 blocks D-1 and D-2 dopamine receptors in rat neostriatum in vitro.
Plantjé JF; Daus FJ; Hansen HA; Stoof JC
Naunyn Schmiedebergs Arch Pharmacol; 1984 Sep; 327(2):180-2. PubMed ID: 6208489
[TBL] [Abstract][Full Text] [Related]
13. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
[TBL] [Abstract][Full Text] [Related]
14. Acute reserpine treatment induces down regulation of D-1 dopamine receptor associated adenylyl cyclase activity in rat striatum.
Thomas KL; Rose S; Jenner P; Marsden CD
Biochem Pharmacol; 1992 Jul; 44(1):83-91. PubMed ID: 1321631
[TBL] [Abstract][Full Text] [Related]
15. Inactivation of dopamine D-1 or D-2 receptors differentially inhibits stereotypies induced by dopamine agonists in rats.
Arnt J; Hyttel J; Meier E
Eur J Pharmacol; 1988 Oct; 155(1-2):37-47. PubMed ID: 2907491
[TBL] [Abstract][Full Text] [Related]
16. Identification of the enantiomers of SK&F 83566 as specific and stereoselective antagonists at the striatal D-1 dopamine receptor: comparisons with the D-2 enantioselectivity of Ro 22-1319.
O'Boyle KM; Waddington JL
Eur J Pharmacol; 1984 Oct; 106(1):219-20. PubMed ID: 6241567
[No Abstract] [Full Text] [Related]
17. Pituitary and brain D2 receptor density measured in vitro and in vivo in EEDQ treated male rats.
Ekman A; Eriksson E
Life Sci; 1991; 48(4):321-31. PubMed ID: 1824955
[TBL] [Abstract][Full Text] [Related]
18. Effects of inactivation of D1 dopamine receptors on stereotypic and thermic responses to quinpirole (LY 171555).
Double KL; Crocker AD
Neurosci Lett; 1990 Jul; 115(1):81-5. PubMed ID: 1977110
[TBL] [Abstract][Full Text] [Related]
19. Dopamine D-2 receptors inhibit D-1 stimulated cyclic AMP accumulation in striatum but not limbic forebrain.
Kelly E; Nahorski SR
Naunyn Schmiedebergs Arch Pharmacol; 1987 May; 335(5):508-12. PubMed ID: 2441268
[TBL] [Abstract][Full Text] [Related]
20. Similar pharmacological properties of 8-OH-DPAT and alnespirone (S 20499) at dopamine receptors: comparison with buspirone.
Protais P; Lesourd M; Comoy E
Eur J Pharmacol; 1998 Jul; 352(2-3):179-87. PubMed ID: 9716353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
